Michigan House Bill HB4468

Michigan 2025-2026 Regular Session

• Introduced: 5/7/25
• Refer: 5/7/25

Caption

Insurance: health insurers; coverage for adverse consequences related to gender transition and reversal of gender transition; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406ww.

Impact

The bill is significant in its potential implications for health insurance practices in Michigan, as it mandates that insurers address not only the transition process but also the follow-up care and possible complications that can arise. By ensuring that individuals who have undergone gender transition are afforded the same coverage for complications and reversals as they are for the transition itself, the bill seeks to enhance the overall healthcare provision for transgender individuals, which can be crucial for their mental and physical wellbeing. This could lead to a more supportive healthcare environment for a traditionally marginalized group.

Summary

House Bill 4468 aims to amend the Insurance Code of 1956 by adding Section 3406ww, which mandates health insurance providers in Michigan to cover a range of medical procedures and treatments related to gender transition. This includes coverage for potential adverse consequences resulting from gender transition procedures or treatments, as well as any necessary testing or screening that monitors the enrollee's mental and physical health on at least an annual basis. Furthermore, the bill requires insurers to provide coverage for procedures aimed at reversing gender transition treatments, regardless of the enrollee's status at the time those treatments were carried out.

Contention

Notably, HB4468 may face opposition from various stakeholders who might argue against the requirements for insurance coverage, citing concerns about costs or philosophical objections to gender transition services. There may also be debates surrounding the implications of mandating insurance companies to cover gender reversal procedures, particularly in terms of resource allocation and the broader debates surrounding healthcare for transgender individuals. As these discussions unfold, the bill could engender substantial public discourse regarding gender identity, healthcare access, and the role of insurers in personal medical decisions.